Literature DB >> 16567818

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.

Sabita S Soedamah-Muthu1, John H Fuller, Henrietta E Mulnier, Veena S Raleigh, Ross A Lawrenson, Helen M Colhoun.   

Abstract

OBJECTIVE: To estimate the absolute and relative risk of cardiovascular disease (CVD) in patients with type 1 diabetes in the U.K. RESEARCH DESIGN AND METHODS: Subjects with type 1 diabetes (n = 7,479) and five age- and sex-matched subjects without diabetes (n = 38,116) and free of CVD at baseline were selected from the General Practice Research Database (GPRD), a large primary care database representative of the U.K. population. Incident major CVD events, comprising myocardial infarction, acute coronary heart disease death, coronary revascularizations, or stroke, were captured for the period 1992-1999.
RESULTS: The hazard ratio (HR) for major CVD was 3.6 (95% CI 2.9-4.5) in type 1 diabetic men compared with those without diabetes and 7.7 (5.5-10.7) in women. Increased HRs were found for acute coronary events (3.0 and 7.6 in type 1 diabetic men and women, respectively, versus nondiabetic subjects), coronary revascularizations (5.0 in men, 16.8 in women), and for stroke (3.7 in men, 4.8 in women). Type 1 diabetic men aged 45-55 years had an absolute CVD risk similar to that of men in the general population 10-15 years older, with an even greater difference in women.
CONCLUSIONS: Despite advances in care, these data show that absolute and relative risks of CVD remain extremely high in patients with type 1 diabetes. Women with type 1 diabetes continue to experience greater relative risks of CVD than men compared with those without diabetes.

Entities:  

Mesh:

Year:  2006        PMID: 16567818     DOI: 10.2337/diacare.29.04.06.dc05-1433

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  101 in total

1.  Management of Type 1 Diabetes in Older Adults.

Authors:  Ruban Dhaliwal; Ruth S Weinstock
Journal:  Diabetes Spectr       Date:  2014-02

2.  Decreases in plasma MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in uremic patients during hemodialysis.

Authors:  Li-Che Lu; Chung-Wei Yang; Wen-Yeh Hsieh; Wan-Hsuan Chuang; Yi-Chang Lin; Chih-Sheng Lin
Journal:  Clin Exp Nephrol       Date:  2015-12-28       Impact factor: 2.801

3.  Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.

Authors:  Alia Shatanawi; Maritza J Romero; Jennifer A Iddings; Surabhi Chandra; Nagavedi S Umapathy; Alexander D Verin; Ruth B Caldwell; R William Caldwell
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

4.  Predictors of and survival after incident stroke in type 1 diabetes.

Authors:  Aaron M Secrest; Catherine T Prince; Tina Costacou; Rachel G Miller; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2012-04-25       Impact factor: 3.291

5.  How to survive diabetes.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2009-04       Impact factor: 10.122

6.  Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database.

Authors:  H E Mulnier; H E Seaman; V S Raleigh; S S Soedamah-Muthu; H M Colhoun; R A Lawrenson; C S De Vries
Journal:  Diabetologia       Date:  2006-10-27       Impact factor: 10.122

7.  Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.

Authors:  Petter Bjornstad; Pattara Wiromrat; Richard J Johnson; Rachel Sippl; David Z I Cherney; Randy Wong; Marian J Rewers; Janet K Snell-Bergeon
Journal:  Diabetes Care       Date:  2018-11-27       Impact factor: 19.112

8.  Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study.

Authors:  Sabita S Soedamah-Muthu; Nish Chaturvedi; John H Fuller; Monika Toeller
Journal:  Eur J Nutr       Date:  2012-12-07       Impact factor: 5.614

9.  Simulating lifetime outcomes associated with complications for people with type 1 diabetes.

Authors:  Tom W C Lung; Philip M Clarke; Alison J Hayes; Richard J Stevens; Andrew Farmer
Journal:  Pharmacoeconomics       Date:  2013-06       Impact factor: 4.981

Review 10.  Why do some patients with type 1 diabetes live so long?

Authors:  Larry A Distiller
Journal:  World J Diabetes       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.